AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Apellis Pharmaceuticals, Inc. Director's Dealing 2018

Apr 17, 2018

31417_dirs_2018-04-17_7af10711-17a3-4608-8bb4-ea33dee78a13.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Apellis Pharmaceuticals, Inc. (APLS)
CIK: 0001492422
Period of Report: 2018-04-13

Reporting Person: SCHEIBLER LUKAS (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned	0	Direct